EraGen Biosciences
And markets molecular reagent products and software for diagnostics and research.
Launch date
Employees
Market cap
-
Enterprise valuation
€31m (Public information from Jun 2011)
Madison Wisconsin (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$12.0m | Series A | ||
$34.0m Valuation: $34.0m | Acquisition | ||
| Total Funding | €10.9m | ||